MEDRx licenses percutaneous absorption technology to Daiichi Sankyo

MEDRx has announced that it will jointly develop with Daiichi Sankyo candidate products using its proprietary percutaneous absorption technology NCTSR (Nano Colloid Transdermal System),

Source: MEDRx news release, February 28, 2018

Request a quote for deeper information from
contact@asia-tech.eu

© 2018 Window to Japan - Bio 4 Business - Imprint